Examples of using Cannabinoid in English and their translations into Russian
{-}
-
Colloquial
-
Official
Garth's research shows that the cannabinoid system protects the brain by regulating the other neurotransmitters within it.
signaling molecules that are released from one cell and activating the cannabinoid receptors present on other nearby cells.
The first experience on preparing substances having an effect on cannabinoid receptors can be referred to 1960s 61, 62.
In Luxembourg, all synthetic agonists of cannabinoid receptors have been added to the list of psychotropic substances under control.
so that THC and the cannabinoid receptor would meet.
The cannabinoid receptors, ligands
This new synthetic cannabinoid is not under international control,
Promoting the sharing of information on the potential abuse of and trafficking in synthetic cannabinoid receptor agonists:
Various types of cannabinoid receptors present in all key cells of the nervous system in all brain structures 6, 21.
Nanomolar affinity cannabinoid receptor agonist(Ki values are 62.3
scientists are trying, for the first time, to find the density and location of the cannabinoid receptors in the human brain.
Synthetic cannabinoid receptor agonists with cannabis-like effects are also available in most regions of the world.
Cannabinoid receptors are found in mammalian brain
For example, Ireland and the United Kingdom have placed groups of structurally related synthetic cannabinoid receptor agonists under national control.
which researches and develops cannabinoid formulations as potential therapeutics,
have adopted measures for the control of groups of structurally related synthetic cannabinoid receptor agonists.
However, a large number of synthetic cannabinoid receptor agonists have been synthesized such that non-controlled ones could appear on the market.
During the past several years, synthetic cannabinoid receptor agonists have emerged as a new class of substances of abuse requiring the attention of drug regulators.
Synthetic cannabinoid receptor agonists have emerged as a new class of substances of abuse.
The cannabinoid receptor type 1(CB1) was first cloned in 1990,